SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-05-009478
Filing Date
2005-08-03
Accepted
2005-08-03 09:19:56
Documents
7
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c97160e10vq.htm 10-Q 247244
2 STATEMENT RE: COMPUTATION OF EARNINGS (LOSS) PER SHARE c97160exv11.htm EX-11 13101
3 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS c97160exv12.htm EX-12 11249
4 RULE 13A-14(A) CERTIFICATION OF SIDNEY TAUREL c97160exv31w1.htm EX-31.1 8267
5 RULE 13A-14(A) CERTIFICATION OF CHARLES E. GOLDEN c97160exv31w2.htm EX-31.2 8756
6 SECTION 1350 CERTIFICATION c97160exv32.htm EX-32 5264
7 CAUTIONARY STATEMENT c97160exv99.htm EX-99 12218
  Complete submission text file 0000950137-05-009478.txt   307539
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 05993918
SIC: 2834 Pharmaceutical Preparations